diclofenac has been researched along with eye in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (15.38) | 18.7374 |
1990's | 5 (19.23) | 18.2507 |
2000's | 6 (23.08) | 29.6817 |
2010's | 9 (34.62) | 24.3611 |
2020's | 2 (7.69) | 2.80 |
Authors | Studies |
---|---|
Kulkarni, P; Srinivasan, BD | 1 |
Oglodek, C; Reim, M; Schaffelt, F; Thüne, G; von Kiether, R | 1 |
Agata, M; Araie, M; Fujii, A; Kuboyama, N; Nakajima, A; Tamura, T; Tanaka, M | 1 |
Glasius, E; Noach, EL; Oosterhuis, JA; van Delft, JL; van Haeringen, NJ | 1 |
Lee, DA; Nguyen, KD | 1 |
Ward, DA | 1 |
Bazin, R; Des Marchais, B | 1 |
Abelson, MB; Betts, JG; Gill, D; Koester, JM; Laibovitz, RA; Ostrov, CS; Raizman, MB; Schaich, L; Tauber, J | 1 |
Alcoriza, N; Bellot, JL; García-Cabanes, C; Orts, A; Palmero, M | 1 |
Graff, G; Ke, TL; Spellman, JM; Yanni, JM | 1 |
Amir, A; Chapman, S; Fishbeine, E; Frishman, G; Gilat, E; Kadar, T; Liani, H; Meshulam, J; Sahar, R; Turetz, J | 1 |
Gärtner, S; Hartmann, C; Keipert, S; Pleyer, U; Scholz, M; Schründer, S | 1 |
Hashimoto, T; Hoshina, F; Igarashi, A; Kohno, S; Notsu, Y; Toyoda, Y; Yamada, M | 1 |
Attama, AA; Müller-Goymann, CC; Reichl, S | 1 |
Agnihotri, SM; Vavia, PR | 1 |
Cao, F; Liao, Z; Ping, Q; Wang, Y | 1 |
Ahuja, M; Dhake, AS; Majumdar, DK; Sharma, SK | 1 |
Asasutjarit, R; Fuongfuchat, A; Thanasanchokpibull, S; Veeranondha, S | 1 |
Katara, R; Majumdar, DK | 1 |
Chen, H; Jin, L; Li, X; Luo, Z; Shi, S; Xu, L; Yu, J; Zhang, ZL | 1 |
KuKanich, B; Lanuza, R; Meekins, JM; Rankin, AJ | 1 |
Colaço, R; Filipe, HP; Mata, JL; Pereira, JC; Pereira, JM; Pimenta, AF; Saramago, B; Serro, AP; Valente, A | 1 |
Adelli, GR; Balguri, SP; Bhagav, P; Majumdar, S; Raman, V | 1 |
Sagesaka, A; See, GL; Sugasawa, S; Sugibayashi, K; Todo, H | 1 |
Colussi, JA; Henriksen, ML; Lappin, MR; Martabano, BB; Sharp, JL; Wang, Z | 1 |
Chen, K; Gu, D; Pan, H; Pan, W; Sun, H; Tan, G; Wang, L | 1 |
2 trial(s) available for diclofenac and eye
Article | Year |
---|---|
A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Diclofenac; Double-Blind Method; Eye; Female; Humans; Ketorolac Tromethamine; Male; Middle Aged; Ophthalmic Solutions; Seasons; Tolmetin | 1998 |
Evaluation of systemic absorption and renal effects of topical ophthalmic flurbiprofen and diclofenac in healthy cats.
Topics: Absorption, Physiological; Administration, Ophthalmic; Animals; Cats; Cyclooxygenase Inhibitors; Diclofenac; Eye; Female; Flurbiprofen; Male; Ophthalmic Solutions | 2016 |
24 other study(ies) available for diclofenac and eye
Article | Year |
---|---|
Diclofenac and enolicam as ocular anti-inflammatory drugs in rabbit corneal wound model.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzothiepins; Diclofenac; Eye; Neutrophils; Rabbits; Wound Healing | 1986 |
[Effect of inhibitors of prostaglandin synthesis on the eye].
Topics: Animals; Burns, Chemical; Diclofenac; Eye; Eye Burns; Eye Diseases; Humans; Indomethacin; Inflammation; Neovascularization, Pathologic; Phenylacetates; Postoperative Care; Preoperative Care; Prostaglandin Antagonists; Rabbits | 1983 |
[Ocular penetration of topical diclofenac sodium, a non-steroidal anti-inflammatory drug, in rabbit eye].
Topics: Animals; Anti-Inflammatory Agents; Aqueous Humor; Biological Transport; Cornea; Diclofenac; Eye; Male; Ophthalmic Solutions; Phenylacetates; Rabbits | 1984 |
A comparison of the effects of non-steroidal compounds on the disruption of the blood-aqueous barrier.
Topics: Animals; Anti-Inflammatory Agents; Aqueous Humor; Diclofenac; Eye; Eye Proteins; Flurbiprofen; Hydrogen-Ion Concentration; Indomethacin; Rabbits | 1982 |
In vitro evaluation of antiproliferative potential of topical cyclooxygenase inhibitors in human Tenon's fibroblasts.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Connective Tissue; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Eye; Fibroblasts; Flurbiprofen; Humans; Mitosis; Piroxicam; Suprofen | 1993 |
Comparative efficacy of topically applied flurbiprofen, diclofenac, tolmetin, and suprofen for the treatment of experimentally induced blood-aqueous barrier disruption in dogs.
Topics: Animals; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Blood-Aqueous Barrier; Diclofenac; Dogs; Eye; Fluorescein; Fluoresceins; Fluorophotometry; Flurbiprofen; Ocular Physiological Phenomena; Ophthalmic Solutions; Random Allocation; Suprofen; Tolmetin | 1996 |
Keratitis associated with presumed polyendocrinopathy syndrome: treatment with fluorometholone and diclofenac sodium.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Diclofenac; Eye; Female; Fluorometholone; Glucocorticoids; Humans; Keratitis; Polyendocrinopathies, Autoimmune | 1995 |
The ocular pharmacokinetics of topical diclofenac is affected by ocular inflammation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Diclofenac; Eye; Keratitis; Male; Rabbits; Uveitis | 1999 |
Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Biotransformation; Cornea; Diclofenac; Eye; Eye Diseases; Humans; In Vitro Techniques; Inflammation; Permeability; Phenylacetates; Prodrugs; Rabbits; Tissue Distribution | 2000 |
Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Dermatologic Agents; Dexamethasone; Diclofenac; Eye; Eye Diseases; Inflammation; Mustard Gas; Rabbits; Volatilization | 2000 |
Ocular drug permeation following experimental excimer laser treatment on the isolated pig eye.
Topics: Animals; Diclofenac; Eye; In Vitro Techniques; Laser Therapy; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Permeability; Pilocarpine; Swine | 2002 |
Effects of nonsteroidal anti-inflammatory drugs on experimental allergic conjunctivitis in Guinea pigs.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens; Benzophenones; Benzopyrans; Bromobenzenes; Conjunctivitis, Allergic; Diclofenac; Dinoprostone; Disease Models, Animal; Evans Blue; Exudates and Transudates; Eye; Guinea Pigs; Histamine; Histamine Release; Immunization; Injections, Intraperitoneal; Injections, Subcutaneous; Ketotifen; Male; Ovalbumin; Propionates; Prostaglandin D2; Pruritus; Therapeutic Irrigation | 2003 |
Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport, Active; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cornea; Diclofenac; Drug Compounding; Eye; Humans; Lipids; Nanoparticles; Particle Size; Permeability; Solubility; Tissue Engineering; X-Ray Diffraction | 2008 |
Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application.
Topics: Animals; Calorimetry, Differential Scanning; Diclofenac; Drug Stability; Eye; Male; Nanoparticles; Nanotechnology; Polymers; Rabbits; Suspensions | 2009 |
Zn-Al-NO(3)-layered double hydroxides with intercalated diclofenac for ocular delivery.
Topics: Administration, Topical; Aluminum Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chemical Precipitation; Chemistry, Pharmaceutical; Diclofenac; Drug Carriers; Drug Compounding; Eye; Female; Hydrogen-Ion Concentration; Hydroxides; Male; Models, Molecular; Molecular Structure; Nanocomposites; Nanotechnology; Ophthalmic Solutions; Particle Size; Povidone; Rabbits; Solvents; Technology, Pharmaceutical; Thermogravimetry; Zinc Compounds | 2011 |
Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic delivery.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Chemical Precipitation; Diclofenac; Eye; Female; Inflammation; Male; Nanostructures; Nanotechnology; Neutrophils; Ophthalmic Solutions; Particle Size; Polymethacrylic Acids; Rabbits; X-Ray Diffraction | 2011 |
Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Chemical Phenomena; Diclofenac; Drug Administration Routes; Drug Compounding; Drug Delivery Systems; Excipients; Eye; Gels; Hot Temperature; Male; Ophthalmic Solutions; Phase Transition; Poloxamer; Rabbits; Sterilization; Transition Temperature | 2011 |
Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Arachidonic Acid; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cornea; Diclofenac; Drug Delivery Systems; Drug Stability; Eye; Goats; Inflammation; Nanoparticles; Particle Size; Permeability; Polymers; Rabbits; Solutions; Spectroscopy, Fourier Transform Infrared; Static Electricity; Surface Properties; Suspensions; X-Ray Diffraction | 2013 |
Thermosensitive PEG-PCL-PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Biological Availability; Cell Survival; Diclofenac; Drug Delivery Systems; Eye; Humans; Hydrogels; Irritants; Male; Ophthalmic Solutions; Polyesters; Polyethylene Glycols; Rabbits; Solubility | 2016 |
Simulation of the hydrodynamic conditions of the eye to better reproduce the drug release from hydrogel contact lenses: experiments and modeling.
Topics: Contact Lenses, Hydrophilic; Diclofenac; Drug Liberation; Eye; Hydrodynamics; Hydrogels; Methacrylates; Microfluidics; Models, Theoretical; Povidone | 2016 |
Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery.
Topics: Administration, Ophthalmic; Administration, Topical; Animals; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diclofenac; Drug Delivery Systems; Eye; Ion Exchange Resins; Male; Ophthalmic Solutions; Organ Culture Techniques; Rabbits | 2017 |
Eyelid skin as a potential site for drug delivery to conjunctiva and ocular tissues.
Topics: Administration, Cutaneous; Aminopyrine; Animals; Antipyrine; Diclofenac; Eye; Lidocaine; ortho-Aminobenzoates; Permeability; Pilocarpine; Rats, Hairless; Rhodamines; Skin; Skin Absorption | 2017 |
Effect of topical administration of 0.1% diclofenac sodium ophthalmic solution at four frequencies on intraocular pressure in healthy Beagles.
Topics: Administration, Ophthalmic; Administration, Topical; Animals; Diclofenac; Dogs; Drug Administration Schedule; Eye; Female; Intraocular Pressure; Male; Ophthalmic Solutions; Tonometry, Ocular | 2020 |
A Novel Carbon Dots/Thermo-Sensitive In Situ Gel for a Composite Ocular Drug Delivery System: Characterization, Ex-Vivo Imaging, and In Vivo Evaluation.
Topics: Animals; Aqueous Humor; Carbon; Cell Death; Chitosan; Diclofenac; Drug Delivery Systems; Drug Liberation; Eye; Gels; Hyaluronic Acid; Irritants; Nanoparticles; Ophthalmic Solutions; Photoelectron Spectroscopy; Rabbits; Spectroscopy, Fourier Transform Infrared; Temperature | 2021 |